| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/17/2023 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 4.5k | $2.14 | $9.7k | | 07/17/2023 |
| 07/17/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 4.5k | $18.11 | $81.9k | | 07/17/2023 |
| 07/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 10k | $2.14 | $21.4k | | 07/03/2023 |
| 07/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 10k | $18.00 | $180k | | 07/03/2023 |
| 05/02/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 693 | $21.15 | $14.7k | | 05/01/2023 |
| 05/01/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 15k | $20.61 | $309.1k | | 05/01/2023 |
| 05/01/2023 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 05/01/2023 |
| 04/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 5.8k | $19.77 | $115.2k | | 04/03/2023 |
| 04/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 04/03/2023 |
| 04/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 9.2k | $19.16 | $175.7k | | 04/03/2023 |
| 03/07/2023 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 139.1k | $23.03 | $3.2M | | 03/07/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 11.9k | $26.80 | $319.6k | | 01/03/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 2.3k | $27.90 | $63.3k | | 01/03/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 791 | $28.78 | $22.8k | | 01/03/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 15 | $29.82 | $447.3 | | 01/03/2023 |
| 01/03/2023 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 01/03/2023 |
| 12/01/2022 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 15k | $18.00 | $270k | | 12/01/2022 |
| 12/01/2022 | Aerovate Therapeutics, Inc. | AVTE | Exercise | Stock Option (Right to Buy) | 15k | $2.14 | $32.1k | | 12/01/2022 |
| 11/01/2022 | Aerovate Therapeutics, Inc. | AVTE | Sale | Common Stock | 1k | $19.50 | $20.2k | | 11/01/2022 |
| 12/14/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 204.5k | $10.61 | $2.2M | | 12/14/2021 |
| 06/29/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 271.2k | $14.00 | $3.8M | | 04/02/2021 |
| 04/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 254.3k | $0.00 | $0 | | 04/02/2021 |
| 04/02/2021 | Aerovate Therapeutics, Inc. | AVTE | Grant | Stock Option (Right to Buy) | 493.4k | $0.00 | $0 | | 04/02/2021 |
| 01/31/2019 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 350k | $2.70 | $945k | | 01/31/2019 |
| 02/16/2018 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 3k | $2.11 | $6.3k | | 02/16/2018 |
| 02/15/2018 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 2.2k | $2.15 | $4.8k | | 02/14/2018 |
| 02/14/2018 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 3.5k | $2.20 | $7.7k | | 02/14/2018 |
| 02/08/2018 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 500k | $2.15 | $1.1M | | 02/08/2018 |
| 01/16/2018 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 10k | $2.36 | $23.6k | | 01/16/2018 |
| 12/14/2017 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 10k | $1.85 | $18.5k | | 12/14/2017 |
| 11/15/2017 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 5.6k | $1.70 | $9.6k | | 11/14/2017 |
| 11/14/2017 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 4.4k | $1.69 | $7.3k | | 11/14/2017 |
| 10/16/2017 | Protara Therapeutics, Inc. | PRTO | Disposition | Common Stock | 10k | $2.31 | $23.1k | | 10/16/2017 |